BIOLASE (BIOL) stock, a world leader in dental lasers, surged 21.15% to $1.26 in the after-hours session. In the typical close, the stock skyrocketed 80.09% from the previous close to reaching $1.04.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Established in 1991, DCA has more than 330 associated dental support organizations in 20 States and is one of the largest multi-brand dental service organizations in the United States. DCA-affiliated practices provide a wide variety of dental care for customers, including general dentistry, endodontics, oral procedures, orthodoxy, pediatric dentistry, and periodontics. By reducing regular administrative duties, DCA gives dentists professional autonomy, job satisfaction, and development opportunities to present every patient with the most acceptable clinical treatment.
- 3 Best Gene Therapy Stocks for long-term Investment
- Two of the Best Pharmaceutical Stocks to Watch for in 2021
WHAT IS HAPPENING THERE AT THE MOMENT…
NASDAQ-listed BIOLASE has announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations (DSOs) with more than 330 affiliated practices in 20 states, to expand laser adoption and hands-on training programs. The Company expects the agreement to lead to a rollout across all DCA offices in 2021.
In the dental industry, the EpicX and Epic Hygiene lasers of BIOLASER are unmatched,” stated Dr. Don Gallo, Chief Clinical Officer of DCA. “In addition to providing new standards for hygiene care, this technology will also ensure a safer environment by reducing aerosolization and addressing the early periodontal disease. A superior patient experience can be created by providing aerosol free, less invasive soft tissue procedures.”
The medical-device sector outperformed the S&P 500 over the past five years. In general, medical-device stocks beat the S&P 500 and other healthcare stocks so far this year. This makes investors think twice about investing in this market since they could earn a profit.